Search Results 71-80 of 16659 for alt

1. Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer - Mayo Clinic

   AST and ALT ≤3× ULN or < 5 ULN for patients with liver metastases. Able to understand and willing to sign an IRB approved written informed consent document ...

2. An Open Label Extension Study Of Cannabidiol (GWP42003-P) In Children And Young Adults With Dravet Or Lennox-Gastaut Syndromes - Mayo Clinic

   ALT or AST > 5 × upper limit of normal (ULN); · ALT or AST > 3 × ULN and (TBL > 2 × ULN or INR > 1.5); · ALT or AST > 3 × ULN with the presence of fatigue, nausea ...

3. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

   ... (ALT) levels as defined below: Patients with early breast cancer: AST and ALT > 1.5 x ULN;; Patients with metastatic breast cancer: AST and ALT > 2.5 x ULN; ...

4. Turkey Tail Mushroom For Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery - Mayo Clinic

   * Serum transaminase [alanine aminotransferase (ALT) or aspartate aminotransferase (AST)] ≤ 1.2 x upper limit of normal (ULN) (obtained ≤ 90 days prior to ...

5. Studying The Effect Of Levocarnitine In Protecting The Liver From Chemotherapy For Leukemia Or Lymphoma - Mayo Clinic

   * Serum glutamate pyruvate transaminase (SGPT) (ALT) =< 225 U/L (=< 5x ULN) (within 7 days prior to enrollment), and. * Note: For the purpose of this study ...

6. An Extension Study To Assess The Safety Of The Use Of Cannabidiol In Children And Young Adults With Dravet Or Lennox-Gastaut Syndromes - Mayo Clinic

   Alanine aminotransferase [ALT] >5 x upper limit of normal [ULN] or total bilirubin [TBL] >2 x ULN; ALT or aspartate aminotransferase (AST) >3 x ULN and ...

7. ACPE Application and Instructions for Clinical Pastoral Education

   ... Day Tel.: Alt Tel.: Fax: Permanent address ...

8. A Study Of NST-6179 In Subjects With Intestinal Failure-Associated Liver Disease (IFALD). - Mayo Clinic

   ALT and AST \<5 × ULN; 2. Total bilirubin ≤2.5 mg/dL in the absence of Gilbert's Syndrome. 3. Serum albumin ≥2.5 g/dL; 4. International normalized ratio ...

9. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

   ... (ALT) and aspartate transaminase (AST) ≤ 2.5 X ULN (upper limit of normal). Part 2 only: plasma total bilirubin ≤ ULN; ALT and/or AST ≤ 1.5 X ULN ...

10. Publications - Lilly H. Wagner, M.D. - Mayo Clinic

    ... Alt E. CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro. Cancer Lett. 2009 Jul 18; 280 (1):65-71 Epub 2009 Mar 14